The FDA cleared the investigational new drug application of IDE849, a potential first-in-class DLL3-targeted antibody-drug ...

The company stated that it has installed 37 systems, which have been used in over 750 multi-specialty surgeries.

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Franklin Biotechnology Discovery Fund's Q1 2025 report covers market trends, key holdings, risks, and outlook—essential ...

Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova: London Friday, May 9, 2025, 18:00 Hrs [IST] Beacon Therapeutics Holdings Limited, a leadi ...

In a phase 3 trial Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions. It was found that ...

General and Administrative (G&A) Expenses. G&A expenses for the three months ended March 31, 2025 were $6.9 million compared to $5.1 million for the same period in 2024. The increase was primarily ...

HHS Secretary Robert F. Kennedy Jr. has made phasing out petroleum-based dyes in the nation’s food supply one of the priorities in his broader initiative to “Make America Healthy Again.” ...

To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward stirrups, brace for the uncomfortable speculum or even ...

Optimal Carnivore has notified customers who purchased the affected products via email, though specific disposal instructions ...

In its 15th year, Verastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination ...

FDA may take enforcement action against a food commodity containing a pesticide chemical residue if the residue is found at a level above the EPA-established tolerance for that commodity or in a ...